Tavassoly, I., Hu, Y., Zhao, S., Mariottini, C., Boran, A., Chen, Y., . . . Iyengar, R. (2019). Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses. Mol Oncol.
Chicago-tyylinen lähdeviittausTavassoly, Iman, et al. "Genomic Signatures Defining Responsiveness to Allopurinol and Combination Therapy for Lung Cancer Identified By Systems Therapeutics Analyses." Mol Oncol 2019.
MLA-viiteTavassoly, Iman, et al. "Genomic Signatures Defining Responsiveness to Allopurinol and Combination Therapy for Lung Cancer Identified By Systems Therapeutics Analyses." Mol Oncol 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.